30683-08-0

Basic information

• Product Name: (3-(benzyloxy)-6-methylpyridin-2-yl)methanol
• Synonyms: (3-(benzyloxy)-6-methylpyridin-2-yl)methanol
• CAS NO: 30683-08-0
• Molecular Formula: C₁₄H₁₅NO₂
• Molecular Weight: 229.2744
• Mol File: 30683-08-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 375.0±37.0 °C(Predicted)
• Appearance: /
• Density: 1.161±0.06 g/cm3(Predicted)
• PKA: 12.78±0.10(Predicted)
• CAS DataBase Reference: (3-(benzyloxy)-6-methylpyridin-2-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-(benzyloxy)-6-methylpyridin-2-yl)methanol(30683-08-0)
• EPA Substance Registry System: (3-(benzyloxy)-6-methylpyridin-2-yl)methanol(30683-08-0)

Safety Data

• Hazardous Substances Data: 30683-08-0(Hazardous Substances Data)

Usage

General Description

The chemical (3-(benzyloxy)-6-methylpyridin-2-yl)methanol is a compound that contains a pyridine ring with a benzyloxy group attached at the 3-position and a methyl group at the 6-position. It also has a hydroxymethyl group attached to the pyridine ring. (3-(benzyloxy)-6-methylpyridin-2-yl)methanol may have potential pharmaceutical or biological applications due to its unique structure and functional groups. It could be used as a building block in the synthesis of organic molecules or as a starting material for the development of new drugs. Further research is needed to fully understand the properties and potential uses of (3-(benzyloxy)-6-methylpyridin-2-yl)methanol.

Upstream product

• 42097-42-7 3-hydroxy-2-hydroxymethyl-6-methylpyridine 
• 100-39-0 benzyl bromide 

Downstream Products

• 154538-03-1 3-hydroxy-6-methyl-2-(2-phenylethyl)pyridine 
• 738521-78-3 3-(benzyloxy)-6-methylpicolinic acid 
• 856842-30-3 3-benzyloxy-2-chloromethyl-6-methyl-pyridine 

Relevant articles and documents

4,4-DIFLUORO-PIPERIDINE-COMPOUNDS

The invention, in a first aspect relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is a 6-membered aromatic ring, or a 5- or 6-membered heteroaromatic ring comprising 1 to 3 heteroatoms selected from S, O and N,

CHEMICAL COMPOUNDS

The invention relates to a novel compound of formula (I) or a stereoisomer, or a racemate or a mixture or a pharmaceutically acceptable salt thereof: wherein: R is phenyl or a 5- or 6-membered heteroaryl ring containing 1 to 3 heteroatoms selected from S, N and O, such rings may be optionally substituted with n groups Q; Q is selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN, SO2CH3 or a group -O[(CR1R2]pQ1; or Q may be a group Q2; Q1 is phenyl, which may be optionally substituted with n substituents selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN, or a group Q2; or corresponds to 2,2-difluoro- benzo[d][1,3]dioxol-4-yl; Q2 is a 5- or 6-membered heteroaryl containing at least one nitrogen atom, which may optionally substituted with n substituents selected from a group consisting of: C1 C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; P is a 6-membered heteroaryl or a 8-1 1 membered bicylic heteroaryl group, which may be substituted with n substituents selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; R1 is hydrogen or C1-C3 alkyl; R2 is hydrogen or C1-C3 alkyl; n is 1, 2 or 3; p is 0, 1 or 2; and with the proviso that when R corresponds to phenyl, P is substituted by at least one CF3; processes for the preparation of those compounds, pharmaceutical compositions containing one or more compounds of formula (I) and their use as dual antagonists of the Orexin 1 and Orexin 2 receptors.

TRISUBSTITUTED AMINE COMPOUND

The present invention relates to a compound of the general formula (1): wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted heterocyclic group, and the like; R1 is an optionally substituted alkyl group, wherein the alkyl group further may optionally be substituted by an optionally substituted homocyclic group, and the like; and R2 is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.